Acquisition of Zentiva by Advent

In September 2018, Advent acquired Zentiva from Sanofi for an enterprise value of €1,919 million.

Bucéphale Finance acted as financial advisor to Advent International in this transaction.

Back >

Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.